| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9552900a6481149b00bdc0536da44de8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 |
| filingDate |
2020-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e89f46b3a4d8361ae01b3b4a833d58be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4396273be75d32d3264cea2b500e4b1d |
| publicationDate |
2020-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020330565-A1 |
| titleOfInvention |
Methods and compositions for pre-emptive treatment of graft versus host disease |
| abstract |
The present invention discloses methods for pre-emptive prophylactic treatment of graft versus host disease (GvHD). The method of the invention comprises the administration of improved dosage regimen of Alpha-1 Antitrypsin (AAT) for pre-emption of acute GvHD. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10960062-B2 |
| priorityDate |
2018-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |